Following the clinical characterization of the initial 11 patients, we undertook direct testing for mutations in the SPG7 gene in patients who demonstrated the above phenotype in a cohort of patients attending the Sheffield Ataxia Centre and HSP clinics. This evidence concerns the gene SPG7 and hereditary spastic paraplegia.